Definitive Contract 75A50122C00013
- Not listed
- Laboratories Nexelis Canada Inc., doing business as Pairimmune, has been awarded a firm fixed-price purchase order valued at $14.56 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this contract, Pairimmune will establish high throughput SARS-CoV-2 binding antibody immunoassay capability and test human serum samples to support the federal government's response to the COVID-19 pandemic. As the prime contractor,...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $204,000.00 firm fixed price purchase order to Laboratories Nexelis Canada Inc. (doing business as Pairimmune), a for-profit organization, to acquire 20 pseudoparticles (30ml each) to support SARS-CoV-2 research for the DPI_SARS-COV-2_VARIANT TRACE project. The award was not set aside and has a completion date of April 30, 2022. Nexelis Group Inc., the parent company of the...
- On November 29, 2021, the Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $38.0 million firm fixed-price definitive contract to Monogram Biosciences, Inc. for the development and delivery of a high-throughput SARS-CoV-2 neutralizing antibody immunoassay capable of qualifying variants and testing human serum samples. The contract, which extends through September 30, 2029, is being performed at Monogram's laboratory facility in South San Francisco, California. As a...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $10.9 million firm fixed price purchase order to The Broad Institute, Inc. for serology and virus neutralization testing in support of coronavirus COVID-19 response efforts. Performance will take place at the prime contractor's Cambridge, Massachusetts location through September 2021. No subcontractors or set aside designations were indicated. This award utilizes the prime...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Battelle Memorial Institute, a large nonprofit research and development organization. The contract, valued at $6,398,512.00, is for clinical sample testing of SARS-CoV-2 vaccine candidates. This is a cost-plus-fixed-fee type contract that will run through April 17, 2025. The contract has several subcontractors, including Integral...
- Battelle Memorial Institute, doing business as Battelle Anniston Operations, has been awarded a firm fixed price purchase order valued at $7.6 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The purpose of this contract is to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples in support of COVID-19 response efforts. Key subcontracts include those for fetal...
- This purchase order, valued at $6.96 million, was awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc. to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples. As a subsidiary of Laboratory Corporation of America Holdings, Monogram will perform this work establishing a testing capability and analyzing samples at its facility in South San...
- This firm fixed-price contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The $9,109,520.00 contract requires Monogram Biosciences to provide rapid screening and testing services to evaluate the efficacy of medical countermeasures against SARS-CoV-2 pseudoviruses, including emerging variants. The base period...
- This is a delivery order contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging infectious diseases including COVID-19 (SARS-CoV-2). The total ceiling value of the contract is $12,290,377.00. The contract is...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Siemens Healthcare Diagnostics Inc. a $13 million firm fixed price purchase order to develop SARS-CoV-2 antigen tests for the Advia Centaur and Atellica IM systems. As the prime contractor, Siemens Healthcare Diagnostics will deliver coronavirus COVID-19 testing capabilities to support the agency's response efforts. The tests will be developed and the contract performed in Norwood,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.7 million firm fixed price definitive contract to Laboratories Nexelis Canada Inc., doing business as Pairimmune, to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials. The contract supports assay development and validation for emerging SARS-CoV-2 variants. Per the solicitation, the one-year base period of performance is from January 2022 through July 2024. There is no set-aside. Funding comes from HHS to support its COVID-19 medical countermeasure programs. As the incumbent, Nexelis Laboratories Canada Inc. will leverage existing capabilities to analyze samples and assess variants under this new contract.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
High Throughput SARS-CoV-2 Binding Antibody Immunoassay for Testing of Clinical Samples and Variant Assessment | 75A50122R00007 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Pre-Solicitation 1/2 | 11/18/21, 9:10 PM | |
High Throughput SARS-CoV-2 Binding Antibody Immunoassay for Testing of Clinical Samples and Variant Assessment | 75A50122R00007 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Award Notice 2/2 | 1/10/22, 8:29 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 12/12/23 | |
| P00003 | Other Administrative Action | $0 | 8/3/23 | |
| P00002 | Other Administrative Action | $0 | 11/30/22 | |
| P00001 | Exercise an Option | $8.2m | 7/26/22 | |
| Not listed | Not listed | $6.5m | 1/4/22 |